Source: Journal of Interferon & Cytokine Research. Unidade: ICB
Subjects: IMUNOLOGIA, IMUNOLOGIA CELULAR, LIPOPOLISSACARÍDEOS, ESCLEROSE MÚLTIPLA, DOENÇAS AUTOIMUNES, PEPTÍDEOS, NECROSE, CITOCINAS, ADJUVANTES IMUNOLÓGICOS, ENCEFALOMIELITE ANIMAL, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, FÁRMACOS IMUNOSSUPRESSORES
ABNT
BORIM, Patricia Aparecida et al. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis. Journal of Interferon & Cytokine Research, v. 42, n. 4, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.1089/jir.2021.0206. Acesso em: 10 nov. 2024.APA
Borim, P. A., Mimura, L. A. N., Pezavento, S. F. G. Z., Polonio, C. M., Peron, J. P. S., Sartori, A., & Silva, T. F. de C. F. (2022). Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis. Journal of Interferon & Cytokine Research, 42( 4), 1-8. doi:10.1089/jir.2021.0206NLM
Borim PA, Mimura LAN, Pezavento SFGZ, Polonio CM, Peron JPS, Sartori A, Silva TF de CF. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis [Internet]. Journal of Interferon & Cytokine Research. 2022 ; 42( 4): 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1089/jir.2021.0206Vancouver
Borim PA, Mimura LAN, Pezavento SFGZ, Polonio CM, Peron JPS, Sartori A, Silva TF de CF. Effect of rapamycin on MOG-Reactive immune cells and lipopolysaccharide-activated microglia: an in vitro approach for screening new therapies for multiple sclerosis [Internet]. Journal of Interferon & Cytokine Research. 2022 ; 42( 4): 1-8.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1089/jir.2021.0206